Ultrasound-Triggered Drug Delivery Systems

Ultrasound-triggered drug delivery harnesses acoustic energy to achieve spatially and temporally controlled release of therapeutics. By focussing ultrasonic waves on target tissues, drug carriers such as microbubbles, droplets, liposomes or polymeric nanoparticles undergo mechanical or thermal transformations—cavitation, sonoporation or mechanochemical bond cleavage—to liberate their payload. These platforms benefit from the deep penetration and non-invasive nature of ultrasound, enabling enhanced permeation through biological barriers, precise dosing and minimised systemic toxicity. Innovations have yielded multifunctional “theranostic” agents that combine imaging contrast and therapy, as well as cascade strategies that sequentially disrupt tumour vasculature and extracellular matrix to facilitate deeper penetration. Applications span oncology, cardiovascular disease and inflammatory disorders. Challenges remain in standardising ultrasound parameters, ensuring reproducibility of carrier response, and conducting rigorous safety evaluations. Future prospects include tailoring carrier composition to individual pathology, integrating real-time feedback control, and advancing regulatory approval to bring these systems into routine clinical practice globally.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Ultrasound-Triggered Drug Delivery Systems publication trend

The graph below shows the total number of articles in ultrasound-triggered drug delivery systems across all publications each year (not limited to Nature Index journals).

Technical terms

Cavitation: Formation, oscillation and collapse of gas bubbles under ultrasound, producing mechanical forces that disrupt carriers or tissues.

Sonoporation: Transient permeabilisation of cell membranes induced by ultrasound-driven bubble activity, facilitating intracellular uptake of therapeutics.

Microbubble: Gas-filled lipid or polymeric sphere that oscillates or collapses under ultrasound, serving as a carrier and trigger for drug release.

Nanocarrier: Nano-sized delivery vehicle (for example liposome, polymeric nanoparticle or mesoporous silica) engineered to protect and transport drugs until ultrasound-triggered release.

Mechanochemistry: Chemical bond cleavage or structural reorganisation induced by mechanical forces, here exploited by ultrasound energy to activate prodrugs or degrade carrier matrices.

References

1. Cascade Ultrasonic Cavitation Enables Microbubble–Nanoparticle Hybrid to Broadly Accumulate and Penetrate into Pancreatic Ductal Adenocarcinoma. Small Structures (2025).
2. Ultrasound‐controlled drug release and drug activation for cancer therapy. Exploration (2021).
3. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues. Theranostics (2020).